Clinical evaluation of the effect of Siddha classical drug santhanathi kuligai for the treatment of FEVER

Clinical evaluation of the effect of santhanathi kuligai for the treatment of kanasuram

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023800

Enrollment

Registered

2020-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J398- Other specified diseases of upperrespiratory tract

Interventions

Intervention1: cantanÌ±Ä?ti kuá¸·ikai: Should be administrated orally thrice a day after food along with ilaneer at a dose 1 pill(130mg) per day for a period of three days Control Intervention1: Not

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with any of the following symptoms will be included in the study 1.Fever of unknown origin 2.Infectious fever with Respiratory symptoms,Urinary tract symptoms,Gastrointestinal symptoms 3.Loss of appetite 4.Constipation.

Exclusion criteria

Exclusion criteria: Subjects with 1.Fever due to malignancy 2.Fever due to trauma 3.Fever due to psychological factors 4.Fever associated with other complications such as HIV,Meningitis Will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
Decrease in temperature, Cough with expectoration, Headache, Difficulty in breathing and other clinical symptoms.Timepoint: 3-5 Days	—

Secondary

Measure	Time frame
Assessment by CBCTimepoint: 5 to 7 days	—

Countries

India

Contacts

Public ContactShyamala K

Government siddha medical college and hospital

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026